We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Clinigen

News List

Clinigen and Mitsubishi Tanabe Initiate European Managed Access Program for Edaravone to Treat ALS b3cnewswire.
June 04, 2018
Clinigen Group plc (AIM: CLIN, ‘Clinigen’), the global pharmaceutical and services company, has partnered with Mitsubishi Tanabe Pharma Corporation (‘MTPC’), to initiate a Managed Access Program (also known as an Early Access Program) in Europe for edarav
Clinigen, Mitsubishi link for early access programme pharmatimes
May 24, 2018
ALS is an idiopathic neurodegenerative disease in which motor neurons selectively degenerate and vanish, affecting around two in 100,000 people worldwide.
Clinigen and Mitsubishi Tanabe Initiate European Managed Access Program for Edaravone to Treat ALS b3cnewswire
May 23, 2018
the global pharmaceutical and services company, has partnered with Mitsubishi Tanabe Pharma Corporation (‘MTPC’),

Previous page 1 2 Next page